Google Alert - hepatitis c

[Guest guest]

Google News Alert for: hepatitis c

Gilead ends mid stage hepatitis C drug studyBusinessWeekGilead Sciences Inc. said Tuesday it stopped a mid stage clinical trial of an experimental hepatitis C drug because of the drug's side effects. ...See all

stories on this topic

The Star-Ledger - NJ.comNJ pharmaceutical companies lead in development of new Hepatitis C treatmentThe Star-Ledger - NJ.comHepatitis C is already a billion-dollar annual business for Merck and will drive growth, said Bergstedt, the company's senior vice president for ...See all stories on this topic

Gilead Sciences halts hepatitis C drug trialsBizjournals.com... an investigational caspase inhibitor, in patients with chronic hepatitis C. City-based Gilead (NASDAQ:GILD) said the decision follows reports of ...See all stories on this topic

Testimony continues in Hepatitis C trialKTNV Las VegasLas Vegas, NV (KTNV) - Two major drug companies are on trial accused of causing the Hepatitis C outbreak in Southern Nevada by the way the anesthetic ...See all stories on this

topic

Adding ANA598 to Standard Hepatitis C Treatment Accelerates Viral Response ...DG News... promotes an accelerated rate of achieving undetectable levels of virus in treatment-naïve patients with hepatitis C virus (HCV) genotype-1, according to ...See all stories on this topic

KXNTHepatitis C Trial UnderwayKXNTOpening statements marked the first day of the civil trial linked to the hepatitis C outbreak in the Las Vegas Valley. On Monday, attorney Eglet, ...See all stories on this topic

First civil trial in Hepatitis C outbreak underwayKTNV Las VegasLas Vegas, NV (KTNV) - The first civil trial stemming from the hepatitis c exposure case is officially underway. Attorney Eglet told jurors the two ...See all

stories on this topic

Setback for Human Genome Pipeline - Analyst BlogBenzingaRecently, Human Genome Sciences Inc. (HGSI) received a setback when the Marketing Authorization Application (MAA) for its hepatitis C candidate Joulferon ...See all stories on this topic

Gilead stops mid-stage trial of hepatitis treatmentReutersO) said it terminated the mid-stage clinical trial of GS-9450 in patients with chronic hepatitis C, a form of liver disease. The decision followed reports ...See all stories

on this topic